Cases & Deals

Axion BioSystems issues Common Stock in Regulation D Rule 506 offering

Clients Axion Biosystems, Inc.

Jones Day represented Axion BioSystems, Inc., a privately held bio-tech start up company, in connection with its issuance of $3.2 million of Common Stock in a Regulation D Rule 506 offering.